SEC Form 4 · accession 0001179110-16-019964
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mathai Mammen
Officer — SVP, Research & Development
Period of report
Feb 20, 2016
Accepted (ET)
Feb 23, 2016 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 20, 2016 | F | 19,844 | $15.65 | D | 198,111 | D |
Table II — derivative securities
No Table II lines on this filing.